Vor Biopharma Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | +875.8% | +672.5% | +219.6% | +23.4% | -29.9% | -31.9% | +224.8% | |
| – | +705.4% | +551.4% | +336.6% | +10.5% | -40.6% | -31.5% | +374.7% | |
| – | +596.0% | +650.7% | +146.8% | -51.8% | -45.7% | +161.3% | +383.8% | |
| – | +596.0% | +650.7% | +327.4% | +11.0% | -40.4% | -33.0% | +395.2% | |
| – | +925.4% | +2,900.7% | -68.6% | +84.4% | – | – | – | |
| – | -71.9% | +1,164.3% | -4.7% | +85.2% | +21.2% | -21.8% | +1,259.5% | |
| – | -71.9% | +366.9% | -0.5% | +29.2% | +18.7% | +19.5% | +35.2% | |
| – | – | – | +113.1% | +77.9% | +17.1% | +10.1% | -93.4% | |
| – | +1,723.7% | +240.7% | -34.6% | +14.7% | -54.0% | +84.7% | +240.7% | |
| – | – | +531.8% | +348.0% | +15.9% | -39.9% | -35.9% | -270.0% | |
| – | – | – | – | – | – | – | – | |
| – | +555.8% | +0.0% | +0.1% | +6.4% | +69.9% | +2.3% | +187.4% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.